Business Context and Reporting Period
Company: Medifast, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: June 30, 2007
Business Overview: Medifast operates in the weight management industry through two primary segments: the "Medifast" segment (Direct, Take Shape for Life, Doctors, and Clinics) and "All Other" (Hi-Energy and Weight Control Centers). The company reported 13,669,098 shares of common stock outstanding as of August 7, 2007.
Key Financial Metrics
| Metric | Six Months Ended June 30, 2007 |
Six Months Ended June 30, 2006 |
Three Months Ended June 30, 2007 |
Three Months Ended June 30, 2006 |
|---|---|---|---|---|
| Revenue | $42,130,000 | $39,137,000 | $22,041,000 | $19,954,000 |
| Gross Profit | $31,709,000 | $29,506,000 | $16,678,000 | $15,101,000 |
| Gross Margin | 75.3% | 75.4% | 75.7% | 75.7% |
| Net Income | $2,282,000 | $3,458,000 | $909,000 | $1,448,000 |
| Diluted EPS | $0.17 | $0.25 | $0.07 | $0.11 |
| Cash & Equivalents | $2,923,000 (as of June 30, 2007) | |||
| Operating Cash Flow | $3,925,000 (Six Months 2007) | |||
| Total Debt | $4,859,000 (Line of Credit + Long-term) |
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 8% year-over-year for the six months ended June 30, 2007, driven by growth in the Take Shape for Life (11% increase), Doctor (15% increase), and Clinic (16% increase) channels. Direct response sales grew 4%.
- Profitability Decline: Net income decreased 34% to $2.3 million for the six-month period. This decline is attributed to significant increases in Selling, General, and Administrative (SG&A) expenses, specifically advertising ($2.5 million increase) and salaries/benefits ($800,000 increase), as the company invested in future growth infrastructure.
- Expense Increases: SG&A expenses rose $4.2 million compared to the prior year. Advertising expense increased from $7.5 million to $10 million for the six-month period. The company also incurred higher costs for outsourced call centers and stock-based compensation.
- Segment Performance: The "Medifast" segment generated $3.9 million in net income for the six months, while the "All Other" segment reported a loss of $1.6 million, though this loss narrowed slightly compared to the prior year due to restructuring and improved clinic performance.
Guidance, Outlook, and Risks
- Management Commentary: Management views the current period as an investment phase. Significant capital was deployed into celebrity endorsement contracts, public relations, and the construction of an in-house call center to improve future advertising effectiveness and customer retention. The company launched an auto-ship program in mid-June 2007.
- Outlook: The company anticipates a tax rate of approximately 36-38% for 2007. Management expects the investments in infrastructure and advertising to drive significant revenue growth in the near future. The Take Shape for Life division saw a 33% increase in active health coaches.
- Risks and Contingencies:
- Litigation: A lawsuit filed by Leonard Z. Sotomeyer regarding consulting agreements remains pending. The company intends to defend vigorously and does not believe the outcome will materially impact operations.
- Seasonality: Historically, November/December are poor sales months, while January/February are strong. However, management notes seasonality is decreasing as consumers view the products as year-round health solutions.
- Regulatory Compliance: The company continues to invest in systems and personnel to maintain Sarbanes-Oxley compliance.
Key Facts for Investor Verification
- Advertising ROI: Verify the effectiveness of the $10 million advertising spend and celebrity endorsements in driving future revenue, as current profits are suppressed by these upfront costs.
- Call Center Transition: Monitor the transition from outsourced call centers to the new in-house infrastructure to confirm projected cost savings and improved closing rates.
- Clinic Expansion: Track the performance of the Medifast Weight Control Centers, which are operating in 9 locations, as management identifies this as a major future profit driver.
- Debt Structure: Note the conversion of $1.5 million of the line of credit into long-term debt during the period and the remaining line of credit balance of $407,000.
- Restatements: Be aware that prior year financial statements (June 30, 2006) were restated to increase amortization expense, reducing prior net income by $27,000.